Evidence map›Paper›PMID 36626553›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

ROCK2 interacts with p22phox to phosphorylate p47phox and to control NADPH oxidase activation in human monocytes.

Asma Tlili, Coralie Pintard, Margarita Hurtado-Nedelec, Dan Liu, Viviana Marzaioli, Nathalie Thieblemont, Pham My-Chan Dang, Jamel El-Benna

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 3 countries.

Asma TliliInstitut national de la santé et de la recherche médicale (INSERM) U1149, Centre national de la recherche scientifique (CNRS) Equipe de recherche labellisée (ERL) 8252, Centre de Recherche sur l'Inflammation, Université de Paris-Cité, Laboratoire d'Excellence Inflamex, Faculté de Médecine Xavier Bichat, Paris F-75018, France.ORCID 0000-0003-3963-6527
Coralie PintardInstitut national de la santé et de la recherche médicale (INSERM) U1149, Centre national de la recherche scientifique (CNRS) Equipe de recherche labellisée (ERL) 8252, Centre de Recherche sur l'Inflammation, Université de Paris-Cité, Laboratoire d'Excellence Inflamex, Faculté de Médecine Xavier Bichat, Paris F-75018, France.
Margarita Hurtado-NedelecInstitut national de la santé et de la recherche médicale (INSERM) U1149, Centre national de la recherche scientifique (CNRS) Equipe de recherche labellisée (ERL) 8252, Centre de Recherche sur l'Inflammation, Université de Paris-Cité, Laboratoire d'Excellence Inflamex, Faculté de Médecine Xavier Bichat, Paris F-75018, France.
Dan LiuInstitut national de la santé et de la recherche médicale (INSERM) U1149, Centre national de la recherche scientifique (CNRS) Equipe de recherche labellisée (ERL) 8252, Centre de Recherche sur l'Inflammation, Université de Paris-Cité, Laboratoire d'Excellence Inflamex, Faculté de Médecine Xavier Bichat, Paris F-75018, France.
Viviana MarzaioliInstitut national de la santé et de la recherche médicale (INSERM) U1149, Centre national de la recherche scientifique (CNRS) Equipe de recherche labellisée (ERL) 8252, Centre de Recherche sur l'Inflammation, Université de Paris-Cité, Laboratoire d'Excellence Inflamex, Faculté de Médecine Xavier Bichat, Paris F-75018, France.ORCID 0000-0001-9410-0835
Nathalie ThieblemontInstitut national de la santé et de la recherche médicale (INSERM) U1149, Centre national de la recherche scientifique (CNRS) Equipe de recherche labellisée (ERL) 8252, Centre de Recherche sur l'Inflammation, Université de Paris-Cité, Laboratoire d'Excellence Inflamex, Faculté de Médecine Xavier Bichat, Paris F-75018, France.ORCID 0000-0002-8898-9217
Pham My-Chan DangInstitut national de la santé et de la recherche médicale (INSERM) U1149, Centre national de la recherche scientifique (CNRS) Equipe de recherche labellisée (ERL) 8252, Centre de Recherche sur l'Inflammation, Université de Paris-Cité, Laboratoire d'Excellence Inflamex, Faculté de Médecine Xavier Bichat, Paris F-75018, France.
Jamel El-BennaInstitut national de la santé et de la recherche médicale (INSERM) U1149, Centre national de la recherche scientifique (CNRS) Equipe de recherche labellisée (ERL) 8252, Centre de Recherche sur l'Inflammation, Université de Paris-Cité, Laboratoire d'Excellence Inflamex, Faculté de Médecine Xavier Bichat, Paris F-75018, France.ORCID 0000-0001-5733-216X
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Monocytes play a key role in innate immunity by eliminating pathogens, releasing high levels of cytokines, and differentiating into several cell types, including macrophages and dendritic cells. Similar to other phagocytes, monocytes produce superoxide anions through the NADPH oxidase complex, which is composed of two membrane proteins (p22phox and gp91phox/NOX2) and four cytosolic proteins (p47phox, p67phox, p40phox and Rac1). The pathways involved in NADPH oxidase activation in monocytes are less known than those in neutrophils. Here, we show that p22phox is associated with Rho-associated coiled-coil kinase 2 (ROCK2) in human monocytes but not neutrophils. This interaction occurs between the cytosolic region of p22phox (amino acids 132 to 195) and the coiled-coil region of ROCK2 (amino acids 400 to 967). Interestingly, ROCK2 does not phosphorylate p22phox, p40phox, p67phox, or gp91phox in vitro but phosphorylates p47phox on Ser304, Ser315, Ser320 and Ser328. Furthermore, KD025, a selective inhibitor of ROCK2, inhibited reactive oxygen species (ROS) production and p47phox phosphorylation in monocytes. Specific inhibition of ROCK2 expression in THP1-monocytic cell line by siRNA inhibited ROS production. These data show that ROCK2 interacts with p22phox and phosphorylates p47phox, and suggest that p22phox could be a shuttle for ROCK2 to allow p47phox phosphorylation and NADPH oxidase activation in human monocytes.

Indexed as

MonocytesNADPH Oxidasesrho-Associated KinasesAmino AcidsHumansPhosphoproteinsReactive Oxygen SpeciesAmino AcidsCYBA protein, humanNADPH Oxidasesneutrophil cytosolic factor 1PhosphoproteinsReactive Oxygen Speciesrho-Associated KinasesROCK2 protein, humanmonocyteNADPH oxidase/NOX2p22phoxp47phoxROCK2

Identifiers

PMID36626553
PMCPMC9934299
OpenAlexW4315435508

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.